<DOC>
	<DOCNO>NCT00241384</DOCNO>
	<brief_summary>The primary purpose study evaluate two treatment regimen prostate cancer , prostate implant 20 Gy external beam radiation therapy versus prostate implant 0 Gy external beam radiation therapy . Patients diagnosed intermediate risk prostate cancer age 40 80 chosen brachytherapy without external beam radiation therapy intend treatment eligible offer participation .</brief_summary>
	<brief_title>Low Dose Supplemental External Radiation With Pd-103 Versus Pd-103 Alone Prostate Cancer</brief_title>
	<detailed_description>Approximately 250,000 men currently diagnose prostatic cancer United States year . Of , 70 % stage T1 T2 disease ( apparently limit prostate gland ) . Clinically localized prostate cancer spectrum disease , range good prognosis poor prognosis . Patients PSA 10 ng/ml Gleason score 7 10 referred intermediate risk , approximately 80 % chance cure . Implantation radioactive source directly prostate ( brachytherapy ) delivers high , localized radiation dose spar bladder rectum . Brachytherapy well establish tumor site , become standard treatment prostate cancer . Establishing good quality implant alone effective implant plus beam radiation allow u routinely drop use beam radiation , change policy decrease risk complication , convenient patient , low treatment cost .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Patients previously untreated prostatic cancer . Must PSA 1020 ng/ml , Gleason 7 9 Patients proven regional lymph node involvement exclude .</criteria>
	<gender>Male</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Prostatic Cancer</keyword>
	<keyword>Brachytherapy</keyword>
	<keyword>Prostatic neoplasm</keyword>
	<keyword>Radiation therapy</keyword>
</DOC>